Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1002/med.21728 http://scihub22266oqcxt.onion/10.1002/med.21728 32864815!8049524!32864815     free     free     free Warning: file_get_contents(https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=32864815&cmd=llinks): Failed to open stream: HTTP request failed! HTTP/1.1 429 Too Many Requests in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 215       Med+Res+Rev 2021 ; 41 (1): 5-28 Nephropedia Template TP {{tp|p=32864815|t=2021. COVID-19 drug repurposing: A review of computational screening methods, clinical trials, and protein interaction assays |pdf=|usr=}}{{32864815}} gab.com Text COVID-19 drug repurposing: A review of computational screening methods, clinical trials, and protein interaction assays JO: Med Res Rev http://www.kidney.de/pget.php?&tw=1&pmid=32864815 #FOAvip The situation of coronavirus disease 2019 (COVID-19) pandemic is rapidly evolving, and medical researchers around the globe are dedicated to finding cures for the disease. Drug repurposing, as an efficient way for drug development, has received a lot of attention. However, the huge amount of studies makes it challenging to keep up to date with the literature on COVID-19 therapeutic development. This review addresses this challenge by grouping the COVID-19 drug repurposing research into three large groups, including clinical trials, computational research, and in vitro protein-binding experiments. Particularly, to facilitate future drug discovery and the creation of effective drug combinations, drugs are organized by their mechanisms of action and reviewed by their efficacy measured by clinical trials. Providing this subtyping information, we hope this review would serve the scientists, clinicians, and the pharmaceutical industry who are looking at the new therapeutics for COVID-19 treatment. Twit Text FOAVip COVID-19 drug repurposing: A review of computational screening methods, clinical trials, and protein interaction assays ????Med Res Rev http://www.kidney.de/pget.php?&tw=1&pmid=32864815 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=32864815 #FOAvip English Wikipedia <ref>{{Cite pmid|32864815}}</ref> COVID-19 drug repurposing: A review of computational screening methods, clinical trials, and protein interaction assays #MMPMID32864815 Wang X; Guan Y Med Res Rev 2021[Jan]; 41 (1): 5-28 PMID32864815show ga The situation of coronavirus disease 2019 (COVID-19) pandemic is rapidly evolving, and medical researchers around the globe are dedicated to finding cures for the disease. Drug repurposing, as an efficient way for drug development, has received a lot of attention. However, the huge amount of studies makes it challenging to keep up to date with the literature on COVID-19 therapeutic development. This review addresses this challenge by grouping the COVID-19 drug repurposing research into three large groups, including clinical trials, computational research, and in vitro protein-binding experiments. Particularly, to facilitate future drug discovery and the creation of effective drug combinations, drugs are organized by their mechanisms of action and reviewed by their efficacy measured by clinical trials. Providing this subtyping information, we hope this review would serve the scientists, clinicians, and the pharmaceutical industry who are looking at the new therapeutics for COVID-19 treatment. |*COVID-19 Drug Treatment[MESH] |*Clinical Trials as Topic[MESH] |*Drug Repositioning[MESH] |*Protein Interaction Maps[MESH] |Computational Biology/*methods[MESH] |Drug Evaluation, Preclinical/*methods[MESH]COVID-19 drug repurposing: A review of computational screening methods(epmc).pdf DeepDyve Pubget Overpricing